get a key
steadybase-$ company CELU
account_id none on file
legal_name Celularity Inc
ticker CELU
cik 1752828
domain celularity.com
entry_point_account_id none on file
name Celularity Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 7 executives 3 family 0
why_nownone on file
callsnone on file
filings
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our therapeutics.

filing / Apr 30, 2026 / receipt

managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls

filing / Apr 30, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our therapeutics.

filing / Apr 30, 2026 / receipt

managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls

filing / Apr 30, 2026 / receipt

1,000+ sales representatives in orthopedic surgery and sports medicine (through Arthrex Inc)

ir_statement / Sep 15, 2026 / receipt

100+ sales representatives in the eye care market (through Versea Ophthalmology Inc)

ir_statement / Sep 15, 2026 / receipt

40+sales representatives in wound care and general surgery

ir_statement / Sep 15, 2026 / receipt

executives
John R. Haines Senior Executive Vice President - receipt
John Sprague Acting Chief Financial Officer - receipt
Rick Gonzalez Chief Commercial Officer - receipt
familynone on file
upcomingnone on file
changes
2026-06-03 Chief Commercial Officer, appointed sec_8k
2026-03-05 Acting Chief Financial Officer, appointed sec_8k
2022-10-06 Senior Executive Vice President, appointed sec_8k
mcp_package_hint
steadybase-$